HIF1A and posterior cortical atrophy: Moreover, we identified HIF1A as a key driver of malignant progression in prostatic lesions, and Transglutaminase 2 (TGM2), the expression of which correlates with HIF1A signaling in mice and humans, as a potential biomarker of early relapse after prostatectomy in patients with PCa.